American Society of Hematology

Fig. 4.

Fig. 4. Descriptive adjusted EFS of patients who received allogeneic BMT versus those who received chemotherapy. / ■, BMT; ●, chemotherapy. The EFS is adjusted for time to transplant, WBC count, Ph chromosome status, and ploidy. The format is the same as Figure 3.

Descriptive adjusted EFS of patients who received allogeneic BMT versus those who received chemotherapy.

■, BMT; ●, chemotherapy. The EFS is adjusted for time to transplant, WBC count, Ph chromosome status, and ploidy. The format is the same as Figure 3.

This Feature Is Available To Subscribers Only

Sign In or Create an Account